Transcatheter aortic valve replacement in patients with systolic heart failure, aortic stenosis shows limited benefits

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup